Nymox Pharmaceutical Corporation DIO Ratio 2011-2026 | NYMX

Annual DIO Ratio Nymox Pharmaceutical Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	5.46	85.7	186	29.8	61.1	29.7

All numbers in USD currency

Maximum	Minimum	Average
186	5.46	66.2

Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
AbbVie ABBV	91.6	$ 208.84	-2.86 %	$ 369 B	USA
Grifols, S.A. GRFS	0.000171	$ 8.24	-0.12 %	$ 6.83 B	Spain
Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
ANI Pharmaceuticals ANIP	181	$ 74.21	-2.3 %	$ 1.43 B	USA
Autolus Therapeutics plc AUTL	70.7	$ 1.41	2.17 %	$ 375 M	Britain
Cocrystal Pharma COCP	60.5	$ 1.51	48.04 %	$ 17 M	USA
Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
BioMarin Pharmaceutical BMRN	644	$ 55.5	-3.04 %	$ 10.6 B	USA
Adaptive Biotechnologies Corporation ADPT	46.7	$ 14.81	2.63 %	$ 2.25 B	USA
Amgen AMGN	200	$ 347.94	-1.51 %	$ 187 B	USA
Aurinia Pharmaceuticals AUPH	474	$ 15.61	0.9 %	$ 2.1 B	Canada
Bristol-Myers Squibb Company BMY	68.7	$ 59.6	-2.45 %	$ 121 B	USA
BioCryst Pharmaceuticals BCRX	892	$ 9.02	-3.84 %	$ 1.86 B	USA
BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
Cellectis S.A. CLLS	23.3	$ 3.41	1.19 %	$ 116 M	France
Biogen BIIB	351	$ 177.34	-3.5 %	$ 26 B	USA
Axon Enterprise AXON	116	$ 412.81	-2.54 %	$ 31.3 B	USA